This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jun;17(6):682-683.

doi: 10.1016/S1470-2045(16)30094-8. Epub 2016 May 3.

Encouraging results for PD-1 inhibition in gastric cancer

Elizabeth C Smyth¹, David Cunningham²

Affiliations

PMID: 27157490
DOI: 10.1016/S1470-2045(16)30094-8

Comment

Encouraging results for PD-1 inhibition in gastric cancer

Elizabeth C Smyth et al. Lancet Oncol. 2016 Jun.

. 2016 Jun;17(6):682-683.

doi: 10.1016/S1470-2045(16)30094-8. Epub 2016 May 3.

Authors

Elizabeth C Smyth¹, David Cunningham²

Affiliations

¹ Royal Marsden Hospital, Sutton, UK.
² Royal Marsden Hospital, Sutton, UK. Electronic address: david.cunningham@rmh.nhs.uk.

PMID: 27157490
DOI: 10.1016/S1470-2045(16)30094-8

No abstract available

PubMed Disclaimer

Comment on

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.
Muro K, Chung HC, Shankaran V, Geva R, Catenacci D, Gupta S, Eder JP, Golan T, Le DT, Burtness B, McRee AJ, Lin CC, Pathiraja K, Lunceford J, Emancipator K, Juco J, Koshiji M, Bang YJ. Muro K, et al. Lancet Oncol. 2016 Jun;17(6):717-726. doi: 10.1016/S1470-2045(16)00175-3. Epub 2016 May 3. Lancet Oncol. 2016. PMID: 27157491 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information